T-group (topology)
5069.1.3 Fumarate reductase respiratory complex transmembrane subunits
Ligands and drugs
773
Member domains
238
with ligand contacts (≤ 4 Å)
30.8% of members
229
with DrugDomain annotations
29.6% of members
224
with a DrugBank compound
29.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5069.1.3 belongs to X-group 5069 Transmembrane heme-binding four-helical bundle, which binds 7.6 ligand superclasses per 20 proteins, narrower than 50% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 200 |
| DB03047 | EPH | L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine | 69 |
| DB04657 | CBE | Carboxin | 36 |
| DB13075 | MQ7 | Menaquinone 7 | 13 |
| DB04631 | AT5 | Atpenin A5 | 12 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 9 |
| DB08690 | UQ2 | Ubiquinone Q2 | 8 |
| DB08689 | UQ1 | Ubiquinone Q1 | 7 |
| DB02144 | PIE | 1,2-diacyl-sn-glycero-3-phosphoinositol | 6 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 6 |
| DB04327 | PEE | Phosphatidylethanolamine | 5 |
| DB04795 | TTF | Thenoyltrifluoroacetone | 4 |
| DB07490 | BRS | 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL | 4 |
| DB07918 | HQO | 2-heptyl-4-hydroxyquinoline N-oxide | 4 |
| DB00730 | TMG | Thiabendazole | 2 |
| DB02182 | HEB | Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe) | 2 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 2 |
| DB07669 | DMW | 2,3-Dimethyl-1,4-naphthoquinone | 2 |
| DB07671 | DNT | 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL | 2 |
| DB19376 | SLI | Salicylanilide | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 210 |
| EPH | L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE | 69 |
| CBE | 2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE | 37 |
| UNL | Unknown ligand | 28 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 21 |
| FTN | N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide | 14 |
| MQ7 | MENAQUINONE-7 | 13 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 13 |
| AT5 | 3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE | 12 |
| PEV | (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 10 |
| CE1 | O-DODECANYL OCTAETHYLENE GLYCOL | 9 |
| UQ1 | UBIQUINONE-1 | 9 |
| PCI | PENTACHLOROPHENOL | 8 |
| UQ2 | UBIQUINONE-2 | 8 |
| UMQ | UNDECYL-MALTOSIDE | 7 |
| 12J | 2-iodo-N-[3-(1-methylethoxy)phenyl]benzamide | 6 |
| CDN | CARDIOLIPIN | 6 |
| E23 | N-(4-tert-butylbenzyl)-2-(trifluoromethyl)benzamide | 6 |
| F6A | N-biphenyl-3-yl-2-(trifluoromethyl)benzamide | 6 |
| FD8 | N-[3-(pentafluorophenoxy)phenyl]-2-(trifluoromethyl)benzamide | 6 |